Status:
COMPLETED
Exoskeleton Impact on the Quality of Life on Patients With Spinal Muscular Atrophy
Lead Sponsor:
MarsiBionics
Collaborating Sponsors:
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
Conditions:
Spinal Muscular Atrophy Type II
Eligibility:
All Genders
4-9 years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the impact of the use of a pediatric exoskeleton on the quality of life of children, specifically in the psychological and care dimensions. Other objectives ar...
Eligibility Criteria
Inclusion
- Patients between 4 and 9 years old
- Patients with a confirmed diagnostic of Spinal Muscular Atrophy Type II
Exclusion
- Weight over 40 Kg
- Hip-knee distance less than 22 cm or greater than 38cm
- Knee-ankle distance less than 21 cm or greater than 37cm
- Distance between trochanters less than 24 cm or greater than 40cm
- Joint range limit greater than 20º
Key Trial Info
Start Date :
December 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2018
Estimated Enrollment :
3 Patients enrolled
Trial Details
Trial ID
NCT05416034
Start Date
December 1 2017
End Date
August 31 2018
Last Update
June 13 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Ramón y Cajal
Madrid, Spain, 28034